PTJ
SCMP

Paul Tudor Jones’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Paul Tudor Jones’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,586
Closed -$174K – 1355
2017
Q2 		$174K Sell
16,586
-51,185
-76% -$522K 0.01% 914
2017
Q1 		$745K Sell
67,771
-40
-0.1% -$464 0.02% 505
2016
Q4 		$919K Buy
+67,811
New +$946K 0.02% 409
2016
Q3 		– Sell
-18,000
Closed -$197K – 1871
2016
Q2 		$197K Sell
18,000
-25,846
-59% -$289K ﹤0.01% 1412
2016
Q1 		$479K Buy
43,846
+12,838
+41% +$162K 0.01% 968
2015
Q4 		$536K Sell
31,008
-15,917
-34% -$285K 0.02% 831
2015
Q3 		$932K Buy
46,925
+31,716
+209% +$727K 0.03% 416
2015
Q2 		$250K Buy
15,209
+2,000
+15% +$34.7K 0.01% 1211
2015
Q1 		$206K Buy
13,209
+648
+5% +$10K 0.01% 1292
2014
Q4 		$179K Sell
12,561
-200
-2% -$2.11K 0.01% 1295
2014
Q3 		$83K Buy
+12,761
New +$84.8K ﹤0.01% 1288

Other funds holding SCMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Paul Tudor Jones's SCMP Position: Q3 2017 in Review

Paul Tudor Jones sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 16,586 shares — an estimated $174K sold.

Paul Tudor Jones first reported a position in SCMP in Q3 2014 and held it in 11 quarters. The position peaked at $932K in Q3 2015. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • Paul Tudor Jones reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 16,586 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $174K.
  • Paul Tudor Jones first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2014 and held it in 11 quarters.
  • Paul Tudor Jones's Sucampo Pharmaceuticals, Inc. position peaked at $932K in Q3 2015.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.